Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19

CONCLUSION AND RELEVANCE: Overall, the mAbs appeared safe and effective. Sicker, higher-risk mAb-treated veterans faired similarly to less-sick, high-risk veterans not treated. Those who were vaccinated seemed to benefit the most from mAb therapy. Future prospective studies with more matched groups are needed to assess full benefits and risks of mAbs shown to neutralize the predominant variants.PMID:38288555 | DOI:10.1177/10600280231222465
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Source Type: research